Upregulation of MIAT and EZH2 were positively related with LNM, high risk, recurrence and RAS mutation which indicates that MIAT and EZH2 may be played an important role in thyroid cancer progression. This evidence concerns the gene MIAT and thyroid gland carcinoma.